Log in
Enquire now
‌

US Patent 11013743 Cancer treatments using combinations of CDK and ERK inhibitors

Patent 11013743 was granted and assigned to Biomed Valley Discoveries on May, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Biomed Valley Discoveries
Biomed Valley Discoveries
Current Assignee
Biomed Valley Discoveries
Biomed Valley Discoveries
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11013743
Patent Inventor Names
Saurabh Saha0
Dean Welsch0
Gary DeCrescenzo0
Jeffrey James Roix0
Date of Patent
May 25, 2021
Patent Application Number
15105924
Date Filed
December 19, 2014
Patent Primary Examiner
‌
Nissa M Westerberg
Patent abstract

The present invention provides, inter alia, methods, kits, and pharmaceutical compositions for treating or ameliorating the effects of a cancer in a subject in need thereof. The method comprises administering to the subject an effective amount of (i) a first anti-cancer agent, which is BVD-523 or a pharmaceutically acceptable salt thereof and (ii) a second anti-cancer agent, which is a CDK inhibitor or a pharmaceutically acceptable salt thereof, to treat or ameliorate the effects of the cancer. Additional methods for effecting cancer cell death are also provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11013743 Cancer treatments using combinations of CDK and ERK inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us